Smash Notes

Back to Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives, with Priscilla Chan & Mark Zuckerberg.

Why Was Baby KJ's Therapy Aimed at the Liver?

Priscilla Chan says baby KJ's disease was chosen because the therapy had to reach his liver, where a product could be delivered.

The team at CHOP delivered a CRISPR therapy to edit a mutation that would have led to significant neurotoxicity and changed his life. Chan treats that delivery choice as the judgment that unlocks a first application. She also says a human test can still show renal toxicity when a kidney cell carries a receptor the drug was not supposed to hit. A single-cell atlas, including cell types that had not been predicted before the modeling, can show which cells carry that receptor before a human trial. A transcriptomic model is one way to see how different cells react to an intervention.

Grokipedia·Priscilla Chan

Transcript

Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives ·

From the transcript

And then when we test it in human, like we see it happening and we see renal toxicity. And if you have a single-cell atlas that looks at all the different cell types, some of which actually were not predicted before we modeled them, you can start looking at which cells actually do have receptors for the target you thought you were exclusively targeting and be able to predict some of these downstream effects before we get into the human trials.

And I think that that's actually one of the more exciting applications of like a transcriptomic model to understand actually how the different cells will react when you intervene and do something. And, you know, but I think when you think about delivery mechanisms and patient care, you start that's where you start having to be creative about when you ask, like, what disease do you want to care first? There are certain diseases that will be easier to, like, deliver a therapeutic to or the risk reward is makes more sense.

See in transcript

No Priors: Artificial Intelligence | Technology | Startups

More from this episode

  1. Why Does Biohub Build Tools Instead of Cures?Priscilla Chan says Biohub's goal is to build tools that accelerate whole scientific fields so the field can collectively cure disease, and Biohub is not the…
  2. How Does Biohub Model Biology From Proteins Up?Mark Zuckerberg says each layer of biology ends up qualitatively different, so Biohub builds models from proteins upward instead of jumping straight to cells.
  3. Why Does Biohub Release Biology Models as Open Source?Mark Zuckerberg says Biohub releases its biology models as open source so more scientists get the tools sooner, which he expects will move the field faster…
  4. Why Does Biohub Study Systems Instead of One Disease?Mark Zuckerberg says Biohub studies systems such as inflammation and the immune system, rather than one disease, so other groups can use the tools on specific…
  5. How Does Biohub's Protein Model Design Antibodies?Alex Rives says Biohub's new ESM fold model designs single-chain antibodies on a computer, and a lab test of 96 proteins found nanomolar binders, the level…
  6. Can a Model Predict Where a Drug Will Bind?Alex Rives says a model that can simulate where a drug distributes and binds across the body is the beginning of a solution to toxicity.
  7. How Would Biohub's Virtual Cell Link Genes to a Phenotype?Alex Rives says Biohub's virtual cell would model each level of biological complexity and connect the proteomic layer, the genetic layer, and the…

People

More answers like this

More with Sarah Guo

More with Elad Gil

Related episodes

Plays from this note through the rest of the episode.

Weekly highlights

One letter a week.

The notes worth hearing, with the minute they were said.